BRCA2 and ovarian cancer: A total of 1018 people diagnosed with invasive breast and ovarian cancer were tested for BRCA1 and BRCA2. Subsequent multigene panel testing was conducted in Barbados, Cayman Islands, and Dominica for all patients and in Trinidad, Jamaica, and Haiti for those diagnosed younger than age 40 years.